Personalizing therapy in an epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer using PF-00299804 and trastuzumab. uri icon

Overview

publication date

  • August 2, 2010

Research

keywords

  • Antibodies, Monoclonal
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Quinazolinones

Identity

PubMed Central ID

  • PMC1169769

Scopus Document Identifier

  • 78049451972

Digital Object Identifier (DOI)

  • 10.1200/JCO.2010.29.3126

PubMed ID

  • 20679607

Additional Document Info

volume

  • 28

issue

  • 28